FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner

Abstract RNA epigenetics is gaining increased attention for its role in the initiation, metastasis, and drug resistance of tumors. These studies have primarily focused on m6A modification. However, despite being the second most abundant modification found in RNA, the role of m5C modification in pros...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhenda Wang, Abudurexiti Mierxiati, Wenkai Zhu, Tian Li, Hua Xu, Fangning Wan, Dingwei Ye
Format: Article
Language:English
Published: Nature Portfolio 2025-05-01
Series:npj Precision Oncology
Online Access:https://doi.org/10.1038/s41698-025-00904-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850042680741986304
author Zhenda Wang
Abudurexiti Mierxiati
Wenkai Zhu
Tian Li
Hua Xu
Fangning Wan
Dingwei Ye
author_facet Zhenda Wang
Abudurexiti Mierxiati
Wenkai Zhu
Tian Li
Hua Xu
Fangning Wan
Dingwei Ye
author_sort Zhenda Wang
collection DOAJ
description Abstract RNA epigenetics is gaining increased attention for its role in the initiation, metastasis, and drug resistance of tumors. These studies have primarily focused on m6A modification. However, despite being the second most abundant modification found in RNA, the role of m5C modification in prostate cancer remains largely unexplored. Here, we predict an RNA m5C methyltransferase, NSUN2, as a potential therapeutic target for prostate cancer using various bioinformatics approaches, and verify the potential of NSUN2 as a target through multiple preclinical models. Mechanistically, NSUN2 enhances the stability of TRIM28 mRNA by adding m5C modification, promoting the expression of TRIM28. Concurrently, FOXA1, a prostate cancer lineage-specific transcription factor, transcriptionally activates the expression of NSUN2. Our study confirms the clinical potential of targeting RNA epigenetics for the treatment of prostate cancer and elucidates, mechanistically, how RNA epigenetics participates in the complex biological activities within tumors via the FOXA1-NSUN2-TRIM28 axis.
format Article
id doaj-art-c82ea0b64de240968a91840b65c4b0b0
institution DOAJ
issn 2397-768X
language English
publishDate 2025-05-01
publisher Nature Portfolio
record_format Article
series npj Precision Oncology
spelling doaj-art-c82ea0b64de240968a91840b65c4b0b02025-08-20T02:55:28ZengNature Portfolionpj Precision Oncology2397-768X2025-05-019111610.1038/s41698-025-00904-xFOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent mannerZhenda Wang0Abudurexiti Mierxiati1Wenkai Zhu2Tian Li3Hua Xu4Fangning Wan5Dingwei Ye6Department of Urology, Fudan University Shanghai Cancer CenterDepartment of Urology, Gongli Hospital of Shanghai Pudong New AreaDepartment of Urology, First People’s Hospital of KashiTianjin Medical UniversityDepartment of Urology, Fudan University Shanghai Cancer CenterDepartment of Urology, Fudan University Shanghai Cancer CenterDepartment of Urology, Fudan University Shanghai Cancer CenterAbstract RNA epigenetics is gaining increased attention for its role in the initiation, metastasis, and drug resistance of tumors. These studies have primarily focused on m6A modification. However, despite being the second most abundant modification found in RNA, the role of m5C modification in prostate cancer remains largely unexplored. Here, we predict an RNA m5C methyltransferase, NSUN2, as a potential therapeutic target for prostate cancer using various bioinformatics approaches, and verify the potential of NSUN2 as a target through multiple preclinical models. Mechanistically, NSUN2 enhances the stability of TRIM28 mRNA by adding m5C modification, promoting the expression of TRIM28. Concurrently, FOXA1, a prostate cancer lineage-specific transcription factor, transcriptionally activates the expression of NSUN2. Our study confirms the clinical potential of targeting RNA epigenetics for the treatment of prostate cancer and elucidates, mechanistically, how RNA epigenetics participates in the complex biological activities within tumors via the FOXA1-NSUN2-TRIM28 axis.https://doi.org/10.1038/s41698-025-00904-x
spellingShingle Zhenda Wang
Abudurexiti Mierxiati
Wenkai Zhu
Tian Li
Hua Xu
Fangning Wan
Dingwei Ye
FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
npj Precision Oncology
title FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
title_full FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
title_fullStr FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
title_full_unstemmed FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
title_short FOXA1-dependent NSUN2 facilitates the advancement of prostate cancer by preserving TRIM28 mRNA stability in a m5C-dependent manner
title_sort foxa1 dependent nsun2 facilitates the advancement of prostate cancer by preserving trim28 mrna stability in a m5c dependent manner
url https://doi.org/10.1038/s41698-025-00904-x
work_keys_str_mv AT zhendawang foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner
AT abudurexitimierxiati foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner
AT wenkaizhu foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner
AT tianli foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner
AT huaxu foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner
AT fangningwan foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner
AT dingweiye foxa1dependentnsun2facilitatestheadvancementofprostatecancerbypreservingtrim28mrnastabilityinam5cdependentmanner